Archived Medical News Stories

RSSArchived Drug Trial News Stories - July 2010

Date Title Comments Rating
2010-07-30 FDA lifts hold, allows Geron to proceed with Phase I clinical trial of GRNOPC1 in spinal cord injury 0 None
2010-07-30 Pivotal PINNACLE trial results of VELCADE in patients with relapsed/refractory MCL released 0 None
2010-07-30 Anadys Pharmaceuticals reports SVR12 data for ANA598 0 None
2010-07-30 SynCo Bio Partners extends collaboration with Versartis 0 None
2010-07-30 Bio-Path commences dosing in Liposomal Grb-2 Phase I cancer study 0 None
2010-07-30 Curaxis completes reverse merger with Auto Search Cars 0 1
2010-07-30 Anthera initiates PEARL-SC Phase 2b study of A-623 for lupus 0 None
2010-07-30 Orexigen's Contrave COR-I trial results published online in journal Lancet 0 None
2010-07-30 Intra-Cellular Therapies ITI-007 Phase Ib/II clinical trial for schizophrenia meets primary endpoint 0 5
2010-07-30 ACADIA initiates new pimavanserin Phase III trial for Parkinson's disease psychosis 0 None
2010-07-29 Anadys second-quarter net loss decreases to $3.0 million 0 None
2010-07-29 Celgene second-quarter non-GAAP total revenue increases 36% to $850 million 0 None
2010-07-29 AVEO second-quarter total revenues increase to $15.6 million 0 None
2010-07-29 Saint Peter's University joins Curemark's clinical trial program for CM-AT autism treatment 0 None
2010-07-29 Bionovo receives EMA final guidance for advancing Menerba to Phase 3 clinical trials 0 None
2010-07-29 Rotigotine provides clinically relevant improvements in RLS symptoms: Study 0 None
2010-07-29 Nymox provides update on NX-1207 Phase 3 program for benign prostatic hyperplasia 0 None
2010-07-29 Advaxis provides update on survival information from ADXS11-001 phase 1 trial in cervix cancer 0 None
2010-07-29 Pivotal Phase 3 IMPACT study results of PROVENGE published in New England Journal of Medicine 0 None
2010-07-29 Generex reports positive trends in ongoing Oral-lyn buccal insulin spray global Phase III trial 0 None
2010-07-29 Teva Respiratory reports positive results from BDP HFA Nasal Aerosol Phase III trial in seasonal allergic rhinitis 0 5
2010-07-29 Etubics enters Phase I trials for next generation vector vaccines 0 None
2010-07-29 CMX157 shows potential to suppress replication of HIV in Phase 1 clinical trial 0 None
2010-07-29 Limerick to announce new results from LIM-0705 human trials at 23rd Transplantation Society congress 0 None
2010-07-28 Intercept signs CRADA with NIDDK for study of obeticholic acid in nonalcoholic steatohepatitis 0 5
2010-07-28 Kyowa Hakko Kirin initiates Phase 2 trial of ARQ 197 for gastric cancer: ArQule 0 None
2010-07-28 Allos reports topline results from Phase 2b trial of FOLOTYN vs erlotinib in advanced NSCLC 0 None
2010-07-28 Allos reports net loss of $20.0 million for second-quarter 2010 0 None
2010-07-28 Pharmasset announces data from PSI-352938 single ascending dose study 0 None
2010-07-28 BiondVax receives 2010 European Influenza Vaccines Technology Innovation Award 0 None
2010-07-28 Regeneron second-quarter total revenues increase to $115.9 million 0 None
2010-07-28 GSK awards NCCN $4 million grant for study of ofatumumab and pazopanib 0 None
2010-07-28 Antares Pharma reports positive results from Anturol Gel Phase 3 study in overactive bladder patients 0 None
2010-07-28 InterMune second-quarter total revenue decreases to $5.9 million 0 None
2010-07-28 MabCure's MAbs 94% accurate in identifying ovarian cancer 0 None
2010-07-27 Omeros initiates enrollment in OMS302 Phase 2b clinical trial in patients undergoing cataract surgery 0 None
2010-07-27 Iverson Genetic Diagnostics receives CMS approval for Warfarin clinical study 0 None
2010-07-27 Study on interactions between new antitubercular drug candidates SQ109 and TMC207 0 None
2010-07-27 Idenix second-quarter total revenues decrease to $1.3 million 0 None
2010-07-26 QRxPharma reports positive outcome of European Scientific Advice meetings on MoxDuo IR pain therapy 0 None
2010-07-26 Seaside Therapeutics reports positive data from STX209 Phase 2 study in fragile X syndrome 0 None
2010-07-26 Can-Fite's CF102 decreases HCV viral load in liver cancer patients 0 5
2010-07-26 Hospira commences EPO Phase I U.S. clinical trial in renal dysfunction patients with anemia 0 None
2010-07-26 AVEO's initiation of AV-299 Phase 2 trial for lung cancer triggers $750,000 milestone payment to XOMA 0 None
2010-07-26 Onyx reports positive results from carfilzomib Phase 2b 003-A1 study in multiple myeloma 0 None
2010-07-26 Vical's prophylactic Vaxfectin-formulated pDNA vaccine effective against HSV-2 in animal model 1 5
2010-07-26 ESC concerned over interpretation of JUPITER sub-analysis trial results about HDL cholesterol 0 5
2010-07-26 Cerenis, Novasep awarded French Government funding for development of CER-001 HDL mimetic 0 None
2010-07-26 L2FU reports 100% recovery of recent study's lost clinical trial patients 0 None
2010-07-26 North Shore-LIJ Health System seeks oropharynx patients for phase I clinical trial 0 None
2010-07-26 Experimental treatment for sickle cell disease enters Phase 3 clinical trials 3 2
2010-07-23 First patient enrolled in Phase 3 SyNAPSe study of BHR-100 for TBI 0 4
2010-07-23 Tarsa Therapeutics completes patient enrollment in Phase III ORACAL trial of oral calcitonin 0 None
2010-07-23 Update on Phase III Study of oral calcitonin for treatment of osteoarthritis 0 None
2010-07-23 Novartis, Nordic Bioscience to continue oral calcitonin Phase III study in osteoarthritis patients 0 None
2010-07-23 Early HAART during TB treatment prolongs survival of untreated HIV-infected adults: CAMELIA study 0 None
2010-07-23 Boehringer Ingelheim's VERxVE study of nevirapine meets primary endpoint 0 None
2010-07-23 NPS completes patient randomization in GATTEX Phase 3 study for PN dependent short bowel syndrome 0 None
2010-07-23 Cytrx’s tamibarotene achieves molecular complete remission in advanced acute promyelocytic leukemia 0 None
2010-07-23 Independent DSMB recommends Inhibitex to complete FV-100 Phase II clinical trial for shingles 0 None
2010-07-22 Tibotec reports Phase 3 trial results of TMC278 vs. EFV in treatment-naive HIV-1-infected adults 0 None
2010-07-22 Achillion nominates ACH-2928 NS5A clinical candidate for treatment of HCV 0 None
2010-07-22 Tarsa completes enrollment in Phase III ORACAL trial for postmenopausal osteoporosis 0 None
2010-07-22 Merrimack, sanofi-aventis initiate dosing in MM-121 and exemestane combination Phase 2 breast cancer study 0 None
2010-07-22 Repros granted IRB approval to commence low dose Proellex study 0 None
2010-07-22 Somaxon's Silenor Phase 3 clinical data accepted for publication in Sleep, Sleep Medicine journals 0 None
2010-07-22 Fera acquires investigational new drug for treatment of fungal otitis externa 0 None
2010-07-22 Onyx begins Phase 3 trial of carfilzomib in combination with lenalidomide, dexamethasone for relapsed myeloma 0 4
2010-07-22 Ampio Pharmaceuticals commences Optina Phase II clinical trial for diabetic macular edema 0 4
2010-07-21 AMRI initiates enrollment for Phase I study of ALB-127158 for obesity 0 None
2010-07-21 Shionogi-ViiV Healthcare to advance '572 inhibitor into Phase III clinical trials 0 None
2010-07-21 NovaBay reports positive results from NVC-422 Phase 2a proof-of-concept clinical trial for impetigo 0 None
2010-07-21 PROLOR Biotech initiates Phase II clinical trial of biobetter version of human growth hormone 0 None
2010-07-21 AiCuris presents preclinical data on AIC246 anti-HCMV drug at International Herpesvirus Workshop 0 5
2010-07-21 AIDS 2010: Study finds microbicide containing HIV drug lowers infection risk in women by 39% 1 None
2010-07-21 Major turning point in antiepileptic drug testing, development 0 None
2010-07-20 Arcion reports top-line results from ARC-4558 Phase 2b clinical trial for painful diabetic neuropathy 0 None
2010-07-20 Archer Biosciences initiates third drug-escalation cohort in TPI-287 trial for metastatic melanoma 0 None
2010-07-20 KAI Pharmaceuticals completes enrollment in Phase 1 study of KAI-4169 for SHPT 0 None
2010-07-20 Seattle Genetics, Agensys commence ASG-5ME ADC phase I clinical trial for metastatic pancreatic cancer 0 None
2010-07-20 Tenofovir gel reduces HIV by 39% in women: CAPRISA 004 study 0 None
2010-07-20 Global Campaign for Microbicides praises CAPRISA 004 gel trial for women's HIV prevention 0 None
2010-07-20 Aegera reports data from Phase 1 portion of combination AEG35156 Phase 1-2 study for primary liver cancer 0 None
2010-07-20 AVAC applauds CAPRISA 004 microbicide gel trial for preventing sexual transmission of HIV infection 0 None
2010-07-20 Argos' Arcelis immunotherapy reduces viral load in interim analysis of Phase 2 HIV trial 0 None
2010-07-20 Researchers make scientific breakthrough in fight against HIV, genital herpes with a vaginal gel 0 None
2010-07-20 USAID Administrator issues statement on CAPRISA 004 trial for preventing HIV infection in women 0 None
2010-07-20 MDMA (Ecstasy) holds promise for chronic treatment-resistant PTSD 0 None
2010-07-20 Phase 3 study: Tapentadol ER lowers incidence of gastrointestinal adverse events 0 None
2010-07-20 CytRx updates on progress in clinical development of bafetinib in three oncology indications 0 None
2010-07-20 Pfizer suspends chronic low back pain, diabetic peripheral neuropathy studies in tanezumab clinical program 0 None
2010-07-20 ZIOPHARM Oncology commences palifosfamide Phase III clinical trial for metastatic soft tissue sarcoma 0 None
2010-07-20 Abbott presents 48-week PROGRESS study results at 28th International AIDS Conference 0 None
2010-07-20 Benefits of drug L-methionine for neurogenic bladder disorders unclear 0 None
2010-07-19 Amira achieves two clinical development milestones in FLAP program for asthma 0 None
2010-07-19 Oncolytics Biotech receives Canadian approval for combination REOLYSIN Phase 3 trial in head, neck cancer 0 None
2010-07-19 Geron commences enrollment in imetelstat Phase 2 clinical trial for NSCLC 0 5
2010-07-19 Phase 2 CUBICIN study for prosthetic joint infections meets primary endpoint 0 None
2010-07-19 Phase II data on Genetic Immunity's DermaVir vaccine to be presented at XVIII International AIDS Conference 0 5
2010-07-19 ViroStatics to present VS411 Phase II dose-ranging trial data at International AIDS Conference in Vienna 0 1
2010-07-19 FIT Biotech to present results of FIT-06 Phase II clinical trial at XVIII International AIDS 2010 Conference 0 1
2010-07-17 Pacific Shore releases clinical trial results for Burner Balm lip balm 0 None
2010-07-17 Amgen granted FDA priority review designation for denosumab BLA 0 None
2010-07-16 VIVUS disappointed with FDA Advisory Committee's vote on QNEXA for obesity treatment 0 None
2010-07-16 JDD publishes long-term efficacy and tolerability study of PyratineXR Moisturizing Lotion 0 None
2010-07-16 Noscira presents results of Nypta Phase IIa clinical trial for AD at ICAD 2010 0 None
2010-07-15 QR Pharma to present positive clinical data from mechanism of action study in MCI at ICAD 2010 0 2
2010-07-15 Positive microplasmin Phase II trial results published in journal Retina 0 None
2010-07-15 Scientists comment on two clinical trials that use Rituximab to treat small-vessel vasculitis 1 None
2010-07-15 PPMD to provide grant to clinical sites participating in Phase 2 study of ACE-031 0 None
2010-07-15 Two patents issued for GlycoMimetics lead drug candidate, related compounds 0 None
2010-07-15 Enrollment complete in Nabi's first NicVAX Phase III clinical trial for nicotine addiction 0 None
2010-07-15 Aeterna Zentaris' partner Keryx receives FDA orphan-drug designation for perifosine in neuroblastoma 0 None
2010-07-14 Aastrom commences extension study for control patients from Phase 2 IMPACT-DCM clinical trial 0 None
2010-07-14 Phase 1/2 clinical study of bepotastine besilate nasal spray initiated for seasonal allergic rhinitis 0 None
2010-07-14 Presidio Pharmaceuticals completes Phase 1a clinical trial of PPI-461 in healthy subjects 0 4
2010-07-14 Supernus initiates SPN812 Phase IIa clinical trial for ADHD in adults 0 None
2010-07-14 ChemGenex agrees with FDA on potential regulatory path to progress OMAPRO for CML 0 None
2010-07-13 Fredericksburg Oncology invites participants for new metastatic melanoma clinical trial 0 None
2010-07-13 SCENESSE reduces, prevents phototoxic reactions experienced by EPP patients in Phase III trial 0 None
2010-07-13 MAP Pharmaceuticals reports results from LEVADEX PK and safety clinical trial in smokers, non-smokers 0 None
2010-07-13 Innocoll submits SPA for phase 3 clinical trial of Cogenzia for adjuvant treatment of infected diabetic foot ulcers 0 None
2010-07-13 EntreMed announces publication of preclinical data for ENMD-2076 0 None
2010-07-13 Clinical trial initiated to evaluate LibiGel on cognitive function in menopausal women 0 None
2010-07-13 AlphaRx reports positive preclinical results of GAI-122 injectable nanoemulsion for Acute Ischemic Stroke 0 None
2010-07-13 Biodel reports preclinical test results of BIOD620 glucose-regulated or "smart" basal insulin product candidate 0 None
2010-07-13 BioSpecifics' partner Auxilium provides update on XIAFLEX 0 None
2010-07-12 Report on program to develop, test nasally delivered H5N1 vaccine filed with Japan's MHLW 0 None
2010-07-12 Novelos reports positive results from NOV-002 Phase 2 neoadjuvant breast cancer trial 0 None
2010-07-12 Reata funds second pivotal trial of bardoxolone with $78 million equity financing 0 None
2010-07-12 Medivir reports 24-week interim Phase 2b results of TMC435 in treatment-naïve patients with HCV genotype-1 0 None
2010-07-12 Interim progress from Phase III TeloVac study of GV1001 vaccine announced 0 None
2010-07-12 Biogen Idec, Swedish Orphan Biovitrum present results from rFIXFc Phase 1/2a study in hemophilia B 0 5
2010-07-12 bitop's Ectoin allergy nasal spray reduces symptoms of acute allergic rhinitis in two-week crossover study 0 None
2010-07-12 Biogen Idec, Swedish Orphan Biovitrum announce advancement of rFVIIIFc into registrational study 0 None
2010-07-12 Study results show no improvement in overall survival for combination of gemcitabine and Amplimexon 0 None
2010-07-12 Mesoblast schedules formal meeting with FDA to discuss proposed Phase 3 clinical trial program 0 None
2010-07-09 Phase III study results of imiquimod creams for treatment of EGW presented at HPV Conference 0 None
2010-07-09 Phase II trial results of TB-402 presented at International Congress on Thrombosis 0 None
2010-07-09 Bayer HealthCare to present BAY86-6150 rFVIIa Phase I clinical data at XXIX WFH International Congress 0 None
2010-07-08 Rockwell Medical completes End of Phase II meeting with FDA regarding SFP 0 3
2010-07-08 Advanced Life Sciences announces positive results from preclinical studies of Restanza IV 0 None
2010-07-08 Kiadis Pharma receives FDA approval for IND to start pivotal clinical study for ATIR 0 None
2010-07-08 Selvita, Orion collaborate to develop and commercialize SEL103 Alzheimer’s disease program 0 None
2010-07-08 Nymox reports positive new results from pooled analysis of NX-1207 clinical trials for BPH 0 None
2010-07-08 GSK, XenoPort disappointed with GSK1838262/XP13512 phase 2b study for migraine headaches 0 None
2010-07-08 Olaparib shows promising results against inherited forms of breast and ovarian cancer 0 None
2010-07-07 NOXXON to commence multiple ascending dose study of MCP-1 targeting anti-inflammatory Spiegelmer NOX-E36 0 None
2010-07-07 Neoprobe initiates third multi-center Phase 3 clinical study of Lymphoseek 0 None
2010-07-07 Alnylam Pharmaceuticals initiates dosing in Phase I human clinical study with ALN-TTR01 0 None
2010-07-07 Nile completes dosing in CD-NP Phase II study for acute decompensated heart failure 0 None
2010-07-07 Data on activity of Nektar's NKTR-102 in gastrointestinal cancer presented at ESMO 12th World Congress 0 None
2010-07-07 Combination of Biothera's Imprime PGG and Erbitux doubles response rate in colorectal cancer patients 0 None
2010-07-07 Capstone Therapeutics to continue AZX100 Phase 2a trial in dermal scarring to planned 12-month endpoints 0 None
2010-07-07 Genentech submits BLA for trastuzumab-DM1 in advanced HER2-positive breast cancer 0 None
2010-07-07 Debiopharm's achievement of Phase I milestone in Debio 0932 trial triggers $3M milestone payment to Curis 0 None
2010-07-07 Initial Phase II study results of ofatumumab in patients with RRMS announced 0 None
2010-07-07 FDA accepts DBV Technologies' IND for clinical study of VIASKIN for desensitization to peanut allergy 0 None
2010-07-07 Phase Ia clinical trial of SYL040012 for treating elevated intraocular pressure, glaucoma completed 0 None
2010-07-07 Crux Biomedical commences enrollment in Retrieve 2 pivotal U.S. IDE trial of new Vena Cava Filter 0 None
2010-07-07 PuraMed BioScience completes clinical study of LipiGesic M for treating acute migraine 0 None
2010-07-07 FDA grants Angion Biomedica's BB3 therapeutic Fast Track and Orphan Drug product designations 0 5
2010-07-06 Adeona completes $1 million equity financing and provides update on Zinthionein ZC clinical study 0 2
2010-07-06 CTI submits expanded PIP to EMEA for pixantrone MAA for relapsed or refractory, aggressive NHL 0 None
2010-07-06 Nottingham researchers undertake new clinical trial on hearing loss 0 None
2010-07-06 EC approves change in posology of Circadin from 3 weeks to 3 months of treatment 0 None
2010-07-02 Study: ONGLYZA and metformin improve HbA1c levels for adult patients with type 2 diabetes at 76-weeks 0 5
2010-07-02 Shire presents positive data from TKT-025 EXT Phase I/II study for VPRIV in type 1 Gaucher disease patients 0 None
2010-07-02 Chelsea reports positive outcome from DMC review of droxidopa Phase II trial in fibromyalgia 0 2.7
2010-07-02 QR Pharma to present clinical data from mechanism of action study in MCI patients at ICAD 2010 0 None
2010-07-02 Compugen's CGEN-15001 recombinant fusion protein abolishes spontaneous relapses in animal model of MS 0 None
2010-07-02 Genentech's second Phase III ICON7 study of Avastin in ovarian cancer meets primary endpoint 0 None
2010-07-01 ThromboGenics to present microplasmin Phase III trial data at 28th ASRS and 10th EURETINA Congress 0 None
2010-07-01 Studies on VIAject and Vialog presented at 70th American Diabetes Association sessions 0 None
2010-07-01 Oxycyte PFCE decreases mortality after onset of decompression sickness in porcine model study 0 None
2010-07-01 Study results of triple combination therapy in patients with diabetes and hypertension presented at ADA 2010 0 None
2010-07-01 Afinitor more than doubles progression-free survival in advanced pancreatic NET: Study 0 None
2010-07-01 Sepracor announces preliminary results from OMNARIS HFA Phase III study for seasonal allergic rhinitis 0 None
2010-07-01 Evotec commences EVT 101 proof-of-concept Phase II study in treatment-resistant depression 0 None
2010-07-01 CBio achieves recruitment milestone in XToll clinical trial 0 None
2010-07-01 Biospherics acquires worldwide patent rights to Dtagatose from UKRF 0 None
2010-07-01 XOMA reaches enrollment goal of 325 patients for Phase 2b clinical trial of XOMA 052 0 None
2010-07-01 Eisai reports preliminary results from Dacogen for Injection Phase III study in AML 0 None
2010-07-01 Threshold Pharmaceuticals initiates Phase 2 clinical trial of TH-302 in patients with first line pancreatic cancer 0 None
2010-07-01 Cubist commences enrollment in Phase 2 study of CXA-201 for complicated intra-abdominal infections 0 None


185 posts
33 raters